奥扎格雷钠联合巴曲酶治疗进展性脑梗死临床分析

Ozagrel Enzyme Treatment of Progressive Cerebral Infarction Combined Analysis of Sodium Pakistani Song

目的:探讨奥扎格雷钠联合巴曲酶治疗进展性脑梗死的疗效观察。方法:回顾性分析我院收治的进展性脑梗死患者70例的临床资料,随机分为对照组和观察组,各36例,对照组给予奥扎格雷钠治疗,观察组给予奥扎格雷钠联合巴曲酶治疗,均治疗14d。疗程结束后,观察两组的临床疗效、第7、14d神经功能缺损评分情况及其不良反应。结果:总有效率:观察组显著优于对照组(P<0.05)。两组患者治疗第7d、第14d神经功能缺损评分与治疗前比较,显著低于治疗前(P<0.05);观察组治疗第7d、第14d神经功能缺损评分显著低于对照组(P<0.05)。两组患者均未出现不良反应。结论:奥扎格雷钠与巴曲酶联合应用在治疗进展性脑梗死效果显著,安全性高,不良反应低。

Objective： To investigate the efficacy of enzyme treatment of progressive cerebral infarction ozagrel joint Palestinian song. Methods： The clinical data of progressive cerebral infarction 70 cases of patients retrospectively in our hospital, Randomly divided into control group and observation group, the two groups were each 36 cases, in the control group were given ozagrel treatment, observation group was given ozagrel joint Batroxobin, were treated for 14 d. After the treatment, the clinical efficacy was observed between the two groups, the first 7,14 d neurological function and its adverse reactions. Results： The total effective rate： observation group was significantly better than the control group（P〈0.05）. Two groups of patients before the first 7d, Section 14 d neurological deficits compared with before treatment was significantly lower than the treatment（P〈0.05）; observation group therapy first 7d, Section 14 d neurological deficit scores were significantly lower than the control group（P〈0.05）. Two groups of patients were not adverse reactions. Conclusion： Ozagrel combined with batroxobin progress in the treatment of cerebral infarction effect is remarkable, safe, low side effects.